Sandostatin LAR (octreotide): Reviews and patient testimonials
Back to the list of medications
Medication indications
Sandostatin LAR
Treatment of patients with acromegaly in whom surgery is inappropriate or ineffective, or in the interim period until radiotherapy becomes fully effective.Treatment of patients with symptoms associated with functional gastro-entero-pancreatic endocrine tumours e.g. carcinoid tumours with features of the carcinoid syndrome.Treatment of patients with advanced neuroendocrine tumours of the midgut or of unknown primary origin where non-midgut sites of origin have been excluded.Treatment of TSH-secreting pituitary adenomas:• when secretion has not normalised after surgery and/or radiotherapy;• in patients in whom surgery is inappropriate;• in irradiated patients, until radiotherapy is effective.Molecule: octreotide
Patients' opinions on Sandostatin LAR
Conditions related to this medication
Fact sheet
See the fact sheet
Fact sheet
See the fact sheet
Tips and advice of the community